Main Findings
There was a non-significant increase in the number of IUDs pandemic
period compared to pre-pandemic period, 2.85/1000 births compared to
1.22/1000 births (p=0.10).
None of the patients tested positive for SARS-CoV-2 either during their
admission, or during their antenatal course. This was during the early
stages of pandemic when there was lack of access and strict case
criteria for testing.
There was no significant difference in the age, BMI, ethnic category, or
parity between cohorts. There was no significant difference in the rates
of multiple pregnancy, gestational diabetes, pregnancy induced
hypertension, pre-eclampsia, small for gestational age, and in-utero
growth restriction.
There was no significant difference in white cell count (WCC),
neutrophils, neutrophil: lymphocyte ratio, platelets, alanine
transaminase (ALT), C-reactive protein (CRP), activated partial
thromboplastin time (APTT), or prothrombin time (PT). There was a
significant reduction in the mean lymphocyte count in 2020 compared to
2019 (p = 0.03).
Pregnancy outcomes were similar between the two years, with an average
gestation at delivery of 33+0/40 in 2019, and 35+2/40 in 2020. The was
no significant difference in the mode of delivery, estimated blood loss,
or mean birth weight. Pregnancy outcomes are outlined in Table 3.